Insider · CIK 0001283307
Stephen T Worland
Files at EFTR (eFFECTOR Therapeutics, Inc.). First filing -, latest -.
In brief
Stephen T Worland files SEC Form 4 as CEO and director at EFTR (eFFECTOR Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Stephen T Worland has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 15, 2023 | EFTR eFFECTOR Therapeutics, Inc. | AGrant or award Common Stock | +5,979 | $0.50 | $2,973 | 267,204 | Nov 16, 2023 |
Questions about Stephen T Worland
Answered from the filings on this page, as of the latest one.
Is Stephen T Worland buying or selling?
Stephen T Worland has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Stephen T Worland's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stephen T Worland has 0.
Where does Stephen T Worland file Form 4?
Stephen T Worland has filed Form 4 at EFTR (eFFECTOR Therapeutics, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.